Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models (Q28818353)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: December 2016)
edit
Language Label Description Also known as
English
Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models
scientific article (publication date: December 2016)

    Statements

    Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models (English)
    0 references
    0 references
    0 references
    Stuart A Lipton
    0 references
    Anthony Nutter
    0 references
    Kevin M Lopez
    0 references
    James Parker
    0 references
    Kunio Kosaka
    0 references
    Takumi Satoh
    0 references
    Scott R McKercher
    0 references
    Nobuki Nakanishi
    0 references
    1 December 2016
    0 references
    7
    0 references
    12
    0 references
    e2499
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit